156 related articles for article (PubMed ID: 36851682)
1. HAS-Flow May Be an Adequate Method for Evaluating Human T-Cell Leukemia Virus Type 1 Infected Cells in Human T-Cell Leukemia Virus Type 1-Positive Rheumatoid Arthritis Patients Receiving Antirheumatic Therapies: A Retrospective Cross-Sectional Observation Study.
Umekita K; Hashikura Y; Takaki A; Kimura M; Kawano K; Iwao C; Miyauchi S; Kawaguchi T; Matsuda M; Hashiba Y; Hidaka T
Viruses; 2023 Feb; 15(2):. PubMed ID: 36851682
[TBL] [Abstract][Full Text] [Related]
2. The Association of Increase of Human T-Cell Leukemia Virus Type-1 (HTLV-1) Proviral Load (PVL) With Infection in HTLV-1-Positive Patients With Rheumatoid Arthritis: A Longitudinal Analysis of Changes in HTLV-1 PVLs in a Single Center Cohort Study.
Iwamoto N; Araki T; Umetsu A; Takatani A; Aramaki T; Ichinose K; Terada K; Hirakata N; Ueki Y; Kawakami A; Eguchi K
Front Immunol; 2022; 13():887783. PubMed ID: 35603142
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and human T-cell leukemia virus type-1 (HTLV-1) proviral load in HTLV-1-positive patients with rheumatoid arthritis: Baseline data in a single center cohort study.
Eguchi K; Iwanaga M; Terada K; Aramaki T; Tuji Y; Kurushima S; Kojima K; Arima K; Iwamoto N; Ichinose K; Kawakami A; Hirakata N; Ueki Y
Mod Rheumatol; 2020 May; 30(3):471-480. PubMed ID: 30938551
[No Abstract] [Full Text] [Related]
4. Advanced human T-cell leukemia virus type 1 carriers and early-stage indolent adult T-cell leukemia-lymphoma are indistinguishable based on CADM1 positivity in flow cytometry.
Kobayashi S; Watanabe E; Ishigaki T; Ohno N; Yuji K; Nakano K; Yamochi T; Watanabe N; Tojo A; Watanabe T; Uchimaru K
Cancer Sci; 2015 May; 106(5):598-603. PubMed ID: 25703103
[TBL] [Abstract][Full Text] [Related]
5. The time-sequential changes of risk factors for adult T-cell leukemia development in human T-cell leukemia virus-positive patients with rheumatoid arthritis: a retrospective cohort study.
Umekita K; Hashiba Y; Kariya Y; Kubo K; Miyauchi S; Aizawa A; Umeki K; Nomura H; Kawaguchi T; Matsuda M; Takajo I; Hidaka T; Okayama A
Mod Rheumatol; 2019 Sep; 29(5):795-801. PubMed ID: 30246572
[No Abstract] [Full Text] [Related]
6. CD4
Makiyama J; Kobayashi S; Watanabe E; Ishigaki T; Kawamata T; Nakashima M; Yamagishi M; Nakano K; Tojo A; Watanabe T; Uchimaru K
Cancer Sci; 2019 Dec; 110(12):3746-3753. PubMed ID: 31642546
[TBL] [Abstract][Full Text] [Related]
7. Brief Report: Attenuated Effectiveness of Tumor Necrosis Factor Inhibitors for Anti-Human T Lymphotropic Virus Type I Antibody-Positive Rheumatoid Arthritis.
Suzuki T; Fukui S; Umekita K; Miyamoto J; Umeda M; Nishino A; Okada A; Koga T; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Fujikawa K; Aramaki T; Mizokami A; Matsuoka N; Ueki Y; Eguchi K; Sato S; Hidaka T; Origuchi T; Okayama A; Kawakami A; Nakamura H
Arthritis Rheumatol; 2018 Jul; 70(7):1014-1021. PubMed ID: 29471588
[TBL] [Abstract][Full Text] [Related]
8. Use of anti-tumor necrosis factor biologics in the treatment of rheumatoid arthritis does not change human T-lymphotropic virus type 1 markers: a case series.
Umekita K; Umeki K; Miyauchi S; Ueno S; Kubo K; Kusumoto N; Takajo I; Nagatomo Y; Okayama A
Mod Rheumatol; 2015 Sep; 25(5):794-7. PubMed ID: 24252020
[TBL] [Abstract][Full Text] [Related]
9. Treatment with anti–tumor necrosis factor biologic agents in human T lymphotropic virus type I–positive patients with rheumatoid arthritis.
Umekita K; Hidaka T; Miyauchi S; Ueno S; Kubo K; Takajo I; Hashiba Y; Kai Y; Nagatomo Y; Okayama A
Arthritis Care Res (Hoboken); 2014 May; 66(5):788-92. PubMed ID: 24127184
[TBL] [Abstract][Full Text] [Related]
10. Effect of HTLV-1 Infection on the Clinical Course of Patients with Rheumatoid Arthritis.
Umekita K
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891440
[TBL] [Abstract][Full Text] [Related]
11. CADM1/TSLC1 is a novel cell surface marker for adult T-cell leukemia/lymphoma.
Nakahata S; Morishita K
J Clin Exp Hematop; 2012; 52(1):17-22. PubMed ID: 22706526
[TBL] [Abstract][Full Text] [Related]
12. Quantification of T cell clonality in human T cell leukaemia virus type-1 carriers can detect the development of adult T cell leukaemia early.
Wolf SN; Haddow J; Greiller C; Taylor GP; Cook LBM; Rowan AG
Blood Cancer J; 2021 Mar; 11(3):66. PubMed ID: 33771974
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a Cynomolgus Macaque Model of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Direct Inoculation of Adult T-Cell Leukemia Patient-Derived Cell Lines for HTLV-1 Infection.
Urano E; Ueda K; Higuchi M; Furukawa M; Okamura T; Tanaka Y; Yasutomi Y
J Virol; 2022 Nov; 96(22):e0133922. PubMed ID: 36314828
[TBL] [Abstract][Full Text] [Related]
14. High incidence of serious infections requiring hospitalisation in human T-cell leukaemia virus type 1-positive rheumatoid arthritis: A case-controlled observational study.
Hashiba Y; Umekita K; Kimura M; Iwao C; Iwao K; Kariya Y; Kubo K; Miyauchi S; Kudou R; Rikitake Y; Kawaguchi T; Matsuda M; Takajo I; Inoue E; Hidaka T; Okayama A
Mod Rheumatol; 2022 Aug; 32(5):866-874. PubMed ID: 34897491
[TBL] [Abstract][Full Text] [Related]
15. CADM1/TSLC1 Identifies HTLV-1-Infected Cells and Determines Their Susceptibility to CTL-Mediated Lysis.
Manivannan K; Rowan AG; Tanaka Y; Taylor GP; Bangham CR
PLoS Pathog; 2016 Apr; 12(4):e1005560. PubMed ID: 27105228
[TBL] [Abstract][Full Text] [Related]
16. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax
Ishihara Y; Tanaka Y; Kobayashi S; Kawamura K; Nakasone H; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Kimura SI; Tanihara A; Kako S; Uchimaru K; Kanda Y
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724766
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of CADM1/TSLC1/IgSF4 expression in adult T-cell leukemia/lymphoma.
Nakahata S; Saito Y; Marutsuka K; Hidaka T; Maeda K; Hatakeyama K; Shiraga T; Goto A; Takamatsu N; Asada Y; Utsunomiya A; Okayama A; Kubuki Y; Shimoda K; Ukai Y; Kurosawa G; Morishita K
Leukemia; 2012 Jun; 26(6):1238-46. PubMed ID: 22289924
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy.
Fukui S; Nakamura H; Takahashi Y; Iwamoto N; Hasegawa H; Yanagihara K; Nakamura T; Okayama A; Kawakami A
BMC Immunol; 2017 Feb; 18(1):7. PubMed ID: 28158970
[TBL] [Abstract][Full Text] [Related]
19. High Human T-Cell Leukemia Virus Type 1c Proviral Loads Are Associated With Diabetes and Chronic Kidney Disease: Results of a Cross-Sectional Community Survey in Central Australia.
Talukder MR; Woodman R; Pham H; Wilson K; Gessain A; Kaldor J; Einsiedel L
Clin Infect Dis; 2023 Feb; 76(3):e820-e826. PubMed ID: 35903021
[TBL] [Abstract][Full Text] [Related]
20. Proviral loads of human T-lymphotropic virus Type 1 in asymptomatic carriers with different infection routes.
Ueno S; Umeki K; Takajo I; Nagatomo Y; Kusumoto N; Umekita K; Morishita K; Okayama A
Int J Cancer; 2012 May; 130(10):2318-26. PubMed ID: 21780105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
